Indira IVF Refles IPO Papers; Gaudium IVF to Follow

By By Rediff Money Desk, New Delhi
Jul 16, 2025 13:27
Indira IVF confidentially refiles draft IPO papers with Sebi. Gaudium IVF also plans to refile its draft papers, signaling renewed IPO momentum in India's fertility sector.
New Delhi, Jul 16 (PTI) Fertility services provider Indira IVF Hospital Ltd has confidentially filed draft papers with markets regulator Sebi to raise funds through an initial public offering (IPO), according to a public announcement on Wednesday.

The development comes amidst growing investor interest in the Indian assisted reproductive technology (ART) sector, buoyed by increasing awareness, expanding market size, and favourable demographics.

In a public announcement, Indira IVF stated that it has submitted "the pre-filed draft red herring prospectus with Sebi and the stock exchanges... in relation to the proposed initial public offering of its equity shares on the main board of the stock exchanges."

The confidential pre-filing route allows the company to withhold public disclosure of details under the draft red herring prospectus (DRHP). Further, pre-filing DRHP does not guarantee the company will go ahead with the initial public offering (IPO).

Meanwhile, market sources said Gaudium IVF and Women Health, another prominent player in the fertility care space, is also preparing to refile its draft papers in the immediate future, as part of its efforts to tap into capital markets and fuel its next phase of growth.

Both developments signal renewed IPO momentum in India's fertility and women's health segment.

Indira IVF had earlier filed preliminary IPO papers through the confidential route in February. However, it withdrew the documents in March.

The withdrawal of documents for a market debut coincided with the release of a Bollywood biopic on the company's founder, Ajay Murdia. Reports had indicated that Sebi had taken notice of the situation and raised concerns about Indira IVF's potential indirect self-promotion at a time when details of the IPO were not yet disclosed to the public.

Indira IVF Hospital's spokesperson had stated, "The company had decided to withdraw the pre-filed DRHP pursuant to evaluation of various factors and commercial considerations. Reports that suggest any direction from Sebi in this regard are incorrect".

The company has opted for the confidential pre-filing route, which allows it to withhold public disclosure of IPO details under the draft red herring prospectus (DRHP) until later stages. This route is gaining traction among Indian firms aiming for flexibility in their IPO plans.

In recent months, several companies, including INOX Clean Energy, logistics service provider Shadowfax Technologies, Gaja Alternative Asset Management, commerce enablement platform Shiprocket, Tata Capital, edtech unicorn PhysicsWallah and Imagine Marketing, the parent company of wearables brand boAt, chose confidential filings.

In 2024, food delivery giant Swiggy and retail chain Vishal Mega Mart floated their IPOs following similar filings.
Source: PTI
Read More On:
indira ivfipogaudium ivffertilityart sector
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Delhi Air Quality: Jahangirpuri AQI at 498...

Delhi air quality worsens, Jahangirpuri records AQI of 498, falling in the severe...

Rupee Hits Record Low: INR vs USD at 90.58

Rupee falls to a new all-time low of 90.58 against the US dollar amid trade deal...

DRI Seizes Red Sanders Worth Rs 6.26 Cr, 4...

DRI seizes 15 MT of red sanders worth Rs 6.26 crore in Delhi, arrests 4. Illegal export...

UAE Fund to Invest ₹1,000 Cr in Kerala Startups

UAE-based Feeder Fund to invest ₹1,000 crore in Kerala startups over 3 years. Boost...

ECL Aims for 58 MT Output, Mine Closures Planned

Eastern Coalfields Ltd (ECL) targets 58 MT output, plans closure of six underground...

India: Export Potential in Russia

300 Indian products have huge export potential in Russia. Engineering, pharma, agri,...

Gold & Silver Rally: Inflation Data in Focus

Gold and silver prices rally amid inflation data focus. Analysts eye central bank...

India Ranks 3rd in Global AI Vibrancy Index

India ranks 3rd in Stanford University's Global AI Vibrancy tool, surpassing advanced...

EPFOA Urges CPFC: Equip Offices for Compliance

EPFOA urges CPFC to equip field offices with authority & tools to handle default &...

TV Prices to Rise in January: Chip Shortage &...

TV prices are expected to increase in January due to memory chip shortages and a...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com